Studio “Accuracy of alternative TP53 somatic mutational and expression analyses for the prognostication of myelodysplatic syndrome”. Codice: QOL-ONE Trans-1 Cambio Principal Investigator.

Sei in questa pagina: | Home | / Albo Pretorio / Delibere e determine / 2018 / 5 / 8 /

Studio “Accuracy of alternative TP53 soma...

Ricerca avanzata:

Delibere

DELIBERA n. 258/2018 del 08 Maggio 2018

Studio “Accuracy of alternative TP53 somatic mutational and expression analyses for the prognostication of myelodysplatic syndrome”. Codice: QOL-ONE Trans-1 Cambio Principal Investigator.

Allegati disponibili:

pdf (172Kb)